Year 2019: top* 10 papers with the highest R-portion

Topic: Management of Diabetes Mellitus and Cardiovascular Risk

* The top 5% of entries has been removed to reduce statistical anomalies. Further fine-tuning, filtering, and error cleaning are in progress.

Liraglutide in Children and Adolescents with Type 2 Diabetes

YCR = 2019 / 218 /  9.64 

Effect of Additional Oral Semaglutide vs Sitagliptin on Glycated Hemoglobin in Adults With Type 2 Diabetes Uncontrolled With Metformin Alone or With S...

YCR = 2019 / 243 /  9.41 

PIONEER 1: Randomized Clinical Trial of the Efficacy and Safety of Oral Semaglutide Monotherapy in Comparison With Placebo in Patients With Type 2 Dia...

YCR = 2019 / 244 /  9.40 

Diabetic nephropathy: an insight into molecular mechanisms and emerging therapies

YCR = 2019 / 177 /  9.27 

Dapagliflozin and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Previous Myocardial Infarction

YCR = 2019 / 234 /  9.23 

Heart Failure With Preserved Ejection Fraction and Diabetes

YCR = 2019 / 197 /  9.19 

Empagliflozin Reduced Mortality and Hospitalization for Heart Failure Across the Spectrum of Cardiovascular Risk in the EMPA-REG OUTCOME Trial

YCR = 2019 / 216 /  9.12 

Oral Semaglutide Versus Empagliflozin in Patients With Type 2 Diabetes Uncontrolled on Metformin: The PIONEER 2 Trial

YCR = 2019 / 237 /  8.95 

Evaluation of Glomerular Hemodynamic Function by Empagliflozin in Diabetic Mice Using In Vivo Imaging

YCR = 2019 / 210 /  8.79 

Insulin resistance is a cardiovascular risk factor in humans

YCR = 2019 / 155 /  8.75